Heat Biologics - 3 Krebsmittel in der Pipeline!
Seite 149 von 176 Neuester Beitrag: 27.04.24 15:03 | ||||
| Eröffnet am: | 17.09.13 23:22 | von: Balu4u | Anzahl Beiträge: | 5.38 |
| Neuester Beitrag: | 27.04.24 15:03 | von: Highländer49 | Leser gesamt: | 1.169.707 |
| Forum: | Hot-Stocks | Leser heute: | 121 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 147 | 148 | | 150 | 151 | ... 176 > | ||||
https://www.marketwatch.com/story/...and-2020-03-06?mod=mw_quote_news
https://www.marketbeat.com/stocks/NASDAQ/HTBX/institutional-ownership/
Simply Wall St
6 mins ago
Heat Biologics, Inc. (NASDAQ:HTBX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year’s forecasts. The revenue forecast for this year has experienced a facelift, with analysts now much more optimistic on its sales pipeline. Investors have been pretty optimistic on Heat Biologics too, with the stock up 33% to US$0.77 over the past week. It will be interesting to see if today’s upgrade is enough to propel the stock even higher.
Following the upgrade, the consensus from four analysts covering Heat Biologics is for revenues of US$1.7m in 2020, implying a stressful 49% decline in sales compared to the last 12 months. Losses are predicted to fall substantially, shrinking 35% to US$0.34. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$933k and losses of US$0.35 per share in 2020. So there’s been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven.
https://simplywall.st/stocks/us/...ogics-inc-nasdaqhtbx-revenues/amp/
Aber wie immer gilt das ist keine Kaufempfehlung und keine Verkauf Empfehlung von mir jeder muss selbst handeln und sich informieren und muss selbst auf den Knopf drücken